Cieslik, Stefan A.
Zafra, Andrés G.
Driemel, Christiane
Sudarsanam, Monica
Cieslik, Jan-Philipp
Flügen, Georg
Dizdar, Levent
Krieg, Andreas
Vaghiri, Sascha
Ashmawy, Hany
Fung, Stephen
Wilms, Miriam
Terstappen, Leon W. M. M.
Nanou, Afroditi
Neubauer, Hans
Rahbari, Nuh N.
Knoefel, Wolfram T.
Stoecklein, Nikolas H.
Neves, Rui P. L.
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 9 September 2024
Accepted: 18 December 2024
First Online: 8 January 2025
Declarations
:
: Collection of samples from the DU-cohort was approved by the Ethics Committees of the Medical Faculty of the Heinrich Heine University Duesseldorf (Ref-No: 4664/2016). The samples from the HE-cohort are part of a study published by NNR [], and at that time approved by the Ruprecht Karls University Heidelberg. The healthy control samples were collected as part of the IMMC06 clinical trial (NCT00133913) [, ] and the independent M0 R0 cohort from the IMMC-26 study [], both at that time approved by the institutional review boards of the participating centres. All individuals provided written informed consent prior to participation.
: Not applicable.
: N.H.S. declares financial ties to Menarini Silicon Biosystems (CellSearch Assay) in the form of third-party funding for research support, as well as to Illumina (NGS products) in the form of lecture fees. The other authors declare that they have no competing interests.